Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Jan;50(1):67-72.
doi: 10.1373/clinchem.2003.023663.

Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays

Affiliations
Comparative Study

Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays

Leo L M Poon et al. Clin Chem. 2004 Jan.

Abstract

Background: A novel coronavirus (CoV) was recently identified as the agent for severe acute respiratory syndrome (SARS). We compared the abilities of conventional and real-time reverse transcription-PCR (RT-PCR) assays to detect SARS CoV in clinical specimens.

Methods: RNA samples isolated from nasopharyngeal aspirate (NPA; n = 170) and stool (n = 44) were reverse-transcribed and tested by our in-house conventional RT-PCR assay. We selected 98 NPA and 37 stool samples collected at different times after the onset of disease and tested them in a real-time quantitative RT-PCR specific for the open reading frame (ORF) 1b region of SARS CoV. Detection rates for the conventional and real-time quantitative RT-PCR assays were compared. To investigate the nature of viral RNA molecules in these clinical samples, we determined copy numbers of ORF 1b and nucleocapsid (N) gene sequences of SARS CoV.

Results: The quantitative real-time RT-PCR assay was more sensitive than the conventional RT-PCR assay for detecting SARS CoV in samples collected early in the course of the disease. Real-time assays targeted at the ORF 1b region and the N gene revealed that copy numbers of ORF 1b and N gene sequences in clinical samples were similar.

Conclusions: NPA and stool samples can be used for early diagnosis of SARS. The real-time quantitative RT-PCR assay for SARS CoV is potentially useful for early detection of SARS CoV. Our results suggest that genomic RNA is the predominant viral RNA species in clinical samples.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Real-time quantitative RT-PCR assays for SARS CoV. (A), calibration curve for quantitative analysis of ORF 1b gene of SARS CoV. (B), calibration curve for quantitative analysis of N gene of SARS CoV. The Ct is the number of PCR cycles required for the fluorescence intensity of the reaction to reach a predefined threshold. The Ct is inversely proportional to the logarithm of the starting concentration of plasmid DNA. Equations for the regression lines and correlation coefficients are indicated.
Figure 2.
Figure 2.
Change of SARS CoV viral load in samples collected at different days after onset. The upper and lower limits of the boxes and the lines across the boxes indicate the 75th and 25th percentiles and the median, respectively. The upper and lower horizontal bars indicate the 90th and 10th percentiles, respectively. □, NPA samples; ▦, stool samples.
Figure 3.
Figure 3.
Correlation between Ct values of the RT-PCR assay for the ORF 1b region and Ct values of the RT-PCR assay for the N gene. Serially diluted cDNA samples of purified viral genomic RNA were subjected to the ORF 1b and N gene assays, and the linear regression line was deduced from these Ct values is shown as a dotted line in the plot. ○, Ct values for a NPA sample in the assays; ▵, Ct values for a stool sample in the assays.

References

    1. World Health Organization. Acute respiratory syndrome. Wkly Epidemiol Rec 2003;78:73-74. - PubMed
    1. World Health Organization. Communicable disease surveillance & response (CSR). Cumulative number of reported probable cases. http://www.who.int/csr/sars/country/2003_06_17/en/ (Accessed June 18, 2003)..
    1. Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, Lim W, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319-1325. - PMC - PubMed
    1. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-1966. - PubMed
    1. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-1976. - PubMed

Publication types

MeSH terms